18
Brian Ellis Biotechnology Laboratory - UBC May 02, 2001

Brian Ellis Biotechnology Laboratory - UBC May 02, 2001

Embed Size (px)

Citation preview

Page 1: Brian Ellis Biotechnology Laboratory - UBC May 02, 2001

Brian EllisBiotechnology Laboratory - UBCMay 02, 2001

Page 2: Brian Ellis Biotechnology Laboratory - UBC May 02, 2001

Health Canada is mandatedto ensure that the Canadianpublic is not put at risk fromfood or health care products

HC must assess all novel foods

Page 3: Brian Ellis Biotechnology Laboratory - UBC May 02, 2001

From other geographic regions

From new manufacturing processes

Origins of Novel Foods

From plant breeding

Page 4: Brian Ellis Biotechnology Laboratory - UBC May 02, 2001

History of safe human consumption?

Contains known toxicants?

Assessment of Novel Foods

Nutritional value altered?

Page 5: Brian Ellis Biotechnology Laboratory - UBC May 02, 2001

Plant Breeding

Development and evaluationof new genotypes

1. Create variation

2. Select

3. Repeat….

Page 6: Brian Ellis Biotechnology Laboratory - UBC May 02, 2001

1. creates new allelic combinations within a species genome

2. samples mutational / recombinational changes

Classical Plant Breeding

Page 7: Brian Ellis Biotechnology Laboratory - UBC May 02, 2001

Progeny Evaluation

SEXUAL CROSSES

Existing varieties

Distantly related speciesInduced mutants

Closely-related species

LandracesSelections

Page 8: Brian Ellis Biotechnology Laboratory - UBC May 02, 2001

products of plant breedingare generally regarded

as safe

“barley is barley is barley”

• long history• highly selected

Page 9: Brian Ellis Biotechnology Laboratory - UBC May 02, 2001

How do GMO genotypes fit within this model?

derived from known (GRAS)germplasm

very few new genetic elementsadded to parental variety

Page 10: Brian Ellis Biotechnology Laboratory - UBC May 02, 2001

Do a comprehensive (and slowand expensive) food safety assessment ?

The conundrum….

Page 11: Brian Ellis Biotechnology Laboratory - UBC May 02, 2001

…or assume that the genetic background is benign,

The conundrum….

assess traits directly related to the transgene, and

establish “substantial equivalence”

Page 12: Brian Ellis Biotechnology Laboratory - UBC May 02, 2001

comparison of the GMO productwith the conventional

Substantial Equivalence

assesses differences between them

focuses on the transgene and on hallmarks of conventional genotype

Page 13: Brian Ellis Biotechnology Laboratory - UBC May 02, 2001

Strengths

Substantial Equivalence

Focuses on most likely impacts

Uses established methodologies

Page 14: Brian Ellis Biotechnology Laboratory - UBC May 02, 2001

Weaknesses

Substantial Equivalence

Assumes linear responses to genetic change

Uses targeted rather than global analytical methodologies

Page 15: Brian Ellis Biotechnology Laboratory - UBC May 02, 2001

Differential gene expression in the Arabidopsis hypocotyl

wildtypeein 4 mutant

S. Regan, Carleton U.

Page 16: Brian Ellis Biotechnology Laboratory - UBC May 02, 2001

Cellular systems are highly integrated at all levels

PLEIOTROPY

Plant metabolism is extraordinarilyplastic - adapted to creation of new metabolites

Page 17: Brian Ellis Biotechnology Laboratory - UBC May 02, 2001

Fiehn et al, Nature Biotechnology (2000)

Metabolic shifts induced by single-gene changes

in Arabidopsis thalianadgd-1

sdd-1

Page 18: Brian Ellis Biotechnology Laboratory - UBC May 02, 2001

Assume that pleiotropic effectswill occur in GMO organisms

Strengthening Substantial Equivalence

Develop and adopt global profiling methodologies

Focus safety assessment on revealed differences